These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28787285)

  • 1. Novel therapeutic agents in the management of brain metastases.
    Venur VA; Ahluwalia MS
    Curr Opin Oncol; 2017 Sep; 29(5):395-399. PubMed ID: 28787285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment.
    Berghoff AS; Venur VA; Preusser M; Ahluwalia MS
    Am Soc Clin Oncol Educ Book; 2016; 35():e116-22. PubMed ID: 27249713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Checkpoint inhibitors in the treatment of brain metastases of non-small-cell lung cancer and melanoma.
    Kourie HR; Kanaan H; Awada G; Awada AH
    Future Oncol; 2017 May; 13(12):1097-1103. PubMed ID: 28326837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint blockade in patients with melanoma metastatic to the brain.
    Di Giacomo AM; Margolin K
    Semin Oncol; 2015 Jun; 42(3):459-65. PubMed ID: 25965364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy targeting immune check-point(s) in brain metastases.
    Di Giacomo AM; Valente M; Covre A; Danielli R; Maio M
    Cytokine Growth Factor Rev; 2017 Aug; 36():33-38. PubMed ID: 28736183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of brain metastases: breaking a "dogma".
    Di Giacomo AM; Valente M; Cerase A; Lofiego MF; Piazzini F; Calabrò L; Gambale E; Covre A; Maio M
    J Exp Clin Cancer Res; 2019 Oct; 38(1):419. PubMed ID: 31623643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic treatment of melanoma brain metastases].
    Le Rhun É; Mateus C; Mortier L; Dhermain F; Guillot B; Grob JJ; Lebbe C; Thomas M; Jouary T; Leccia MT; Robert C
    Cancer Radiother; 2015 Feb; 19(1):48-54. PubMed ID: 25656856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Checkpoint Inhibitors for Brain Metastases.
    Tan AC; Heimberger AB; Menzies AM; Pavlakis N; Khasraw M
    Curr Oncol Rep; 2017 Jun; 19(6):38. PubMed ID: 28417311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Therapies for Brain Metastases from Breast Cancer.
    Venur VA; Leone JP
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Brain Metastases in the New Era of Checkpoint Inhibition.
    Lauko A; Thapa B; Venur VA; Ahluwalia MS
    Curr Neurol Neurosci Rep; 2018 Aug; 18(10):70. PubMed ID: 30121715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy.
    La-Beck NM; Jean GW; Huynh C; Alzghari SK; Lowe DB
    Pharmacotherapy; 2015 Oct; 35(10):963-76. PubMed ID: 26497482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of systemic therapies in the management of melanoma brain metastases.
    Lyle M; Long GV
    Curr Opin Oncol; 2014 Mar; 26(2):222-9. PubMed ID: 24434634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of melanoma brain metastases.
    Goldinger SM; Panje C; Nathan P
    Curr Opin Oncol; 2016 Mar; 28(2):159-65. PubMed ID: 26809015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapies for melanoma brain metastases: which drug for whom and when?
    Ramanujam S; Schadendorf D; Long GV
    Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic therapy for brain metastases.
    Venur VA; Karivedu V; Ahluwalia MS
    Handb Clin Neurol; 2018; 149():137-153. PubMed ID: 29307351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and Emerging Perspectives on Immunotherapy for Melanoma.
    Daud A
    Semin Oncol; 2015 Dec; 42 Suppl 3():S3-S11. PubMed ID: 26598057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma brain metastasis: overview of current management and emerging targeted therapies.
    Fonkem E; Uhlmann EJ; Floyd SR; Mahadevan A; Kasper E; Eton O; Wong ET
    Expert Rev Neurother; 2012 Oct; 12(10):1207-15. PubMed ID: 23082737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Therapies for Brain Metastases.
    Niranjan A; Lunsford LD; Ahluwalia MS
    Prog Neurol Surg; 2019; 34():125-137. PubMed ID: 31096209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapy in brain metastasis.
    Soffietti R; Trevisan E; Rudà R
    Curr Opin Oncol; 2012 Nov; 24(6):679-86. PubMed ID: 22820413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid remission of symptomatic brain metastases in melanoma by programmed-death-receptor-1 inhibition.
    Lüttmann N; Grätz V; Haase O; Eckey T; Langan EA; Zillikens D; Terheyden P
    Melanoma Res; 2016 Oct; 26(5):528-31. PubMed ID: 27254075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.